National Institute of Allergy and Infectious Diseases Grants

Open National Institute of Allergy and Infectious Diseases grants

• HIV and Other Infectious Diseases Clinical Research Support Services (CRSS)

  Up to $8.7MDeadline: Aug 14, 2026open

  In support of NIAID Division of AIDS (DAIDS) activities, this contract provides a broad range of clinical, laboratory, training and related services t...

• The Impact of the Bone Marrow Niche's Immune Privilege on Psoriatic Arthritis

  Up to $3.4MDeadline: Jul 31, 2029open

  Abstact: Psoriatic arthritis (PsA) is a chronic, inflammatory, and heterogeneous disease that affect various distinct anatomical sites; inclusive of t...

• Developing Inhibitors of Seasonal and Pandemic Influenza Viruses

  Up to $3.4MDeadline: Jul 31, 2029open

  Summary Influenza viruses are a leading cause of human disease due to respiratory viral infection worldwide. It is the overarching objective of this p...

• The uptake and real-world effectiveness of emerging respiratory syncytial virus maternal vaccines and monoclonal antibodies on short- and long-term respiratory morbidities

  Up to $3.3MDeadline: Jul 31, 2029open

  / ABSTRACT Respiratory syncytial virus (RSV) is one of the most common respiratory viruses resulting in significant morbidity and mortality in infants...

• Role of Ubiquitin Ligases and Deubiquitinases in Host Defense against Mycobacterium tuberculosis

  Up to $3.3MDeadline: Jul 31, 2029open

  One mechanism that is central to innate immunity against intracellular pathogens such as Mycobacterium tuberculosis (Mtb) is engagement and targeting ...

• Developing a bioprinted ventilated lung alveolar platform for investigating microbial interactions and influenza response

  Up to $3.2MDeadline: Jul 31, 2029open

  / ABSTRACT Our goal is to understand how the lung microbiome regulates influenza virus infection response by developing a 3D in vitro bioprinted platf...

• Design of single-shot sequential immunization regimens for HIV using atomic layer deposition technology.

  Up to $3.0MDeadline: Jul 31, 2029open

  Project Title: Design of single-shot sequential immunization regimens for HIV using atomic layer deposition technology Project Summary/Abstract 30 lin...

• Characterizing Newly Identified Human Cytomegalovirus Entry Receptors

  Up to $3.0MDeadline: Jul 31, 2029open

  Human cytomegalovirus (HCMV) is a ubiquitous, usually benign virus. Nevertheless, HCMV frequently contributes to rejection of organs in immunosuppress...

• ACE2 immunodecoys for long-lasting immunoprophylaxis against sarbecovirus and merbecoviruses that target human ACE2

  Up to $2.9MDeadline: Jul 31, 2029open

  While vaccines are readily available for SARS-CoV-2, there continues to be significant demand for prophylaxis that are potent and not at risk for vira...

• Regulation of innate immunity by self-adjuvated MRNA vaccines

  Up to $2.7MDeadline: May 31, 2029open

  Mycobacterium tuberculosis (MTB), the causative agent of pulmonary and non-pulmonary tuberculosis (TB), kills nearly 1.2 million people every year, wh...

• The role of synaptopodin during bacterial infection

  Up to $2.6MDeadline: Jul 31, 2029open

  Shigella flexneri is a gram-negative bacterial pathogen that causes diarrhea in humans. Essential for the disease process is the ability of the bacter...

• Estrogen's Impact on IgG Glycomic Modulation of Immunity and Inflammation During HIV

  Up to $2.5MDeadline: Jul 31, 2029open

  Modified PROJECT SUMMARY. Antibodies can trigger a variety of immune responses beyond neutralization, and the glycosylation of antibodies strongly imp...

• EARLY SIGNALS OF THE TRANSITION FROM IMMUNE QUIESCENCE TO ACTIVATION IN THE LIVER ALLOGRAFT MICROENVIRONMENT AND IN THE CIRCULATION

  Up to $1.5MDeadline: Jun 30, 2030open

  Children with liver transplants who are maintained on low dose immunosuppression (IS) with ideal graft function according to clinical, biochemical, an...

• An early life multivalent immunization strategy for induction of neutralization breadth

  Up to $1.3MDeadline: Jun 30, 2030open

  In 2023, adolescents and young people accounted for approximately 25% of new HIV infections globally. The period after weaning but before sexual debut...

• Immunobiology and Physiology of Liver xenograft in the Decedent

  Up to $1.3MDeadline: Jul 31, 2030open

  Recent advances in genetic engineering have enabled significant modifications in porcine organs, such as the removal of glycan sequences linked to hyp...

• Mechanisms of Early-life Immunity Associated with HIV-1 Vaccine-induced Neutralizing Antibody Responses

  Up to $1.2MDeadline: Jun 30, 2030open

  At the end of 2021, an estimated 1.7 million children were living with HIV-1, including 160,000 children who were newly infected (UNAIDS), thus pediat...

• Chemical Grammar of Accumulation in Drug Resistant Acinetobacter baumannii with Subcellular Resolution

  Up to $1.2MDeadline: Jul 31, 2030open

  Multidrug-resistant (MDR) PROJECT SUMMARY Acinetobacter baumannii (A. baumannii) is recognized as one of the most urgent global health threats due to...

• A ProgramPharmacy Chains to Increase PrEP Awareness and Access Among Men

  Up to $1.1MDeadline: Jul 31, 2030open

  Modified Project Summary/Abstract Section This Type 3 Hybrid Effectiveness-Implementation study will evaluate PrEP & Soccer, a multicomponent and mul...

• Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site

  Up to $1.0MDeadline: Nov 30, 2026open

  DMID 24-0003 PROMISE “A prospective, quasi-interventional Phase 4 study of the safety and serology of maternal RSVpreF (ABRYSVO) vs. infant nirsevimab...

• Dissecting innate immune control of intestinal and systemic Yersinia infection

  Up to $1.0MDeadline: Feb 28, 2030open

  Infection by many pathogens leads to the formation of structures termed granulomas, organized clusters of macrophages, neutrophils, and lymphocytes, t...

Where National Institute of Allergy and Infectious Diseases grants go

Recent grant recipients are concentrated in these states. Funders sometimes fund outside their primary states for high-fit projects, so don't self-eliminate solely on geography — check each opportunity's stated eligibility.

How to apply for National Institute of Allergy and Infectious Diseases grants

Most National Institute of Allergy and Infectious Diseases applications require: an organizational profile with mission and programs, a project proposal aligned with the funder's stated priorities, a project budget, and supporting attachments (IRS determination letter, board list, recent financials). Federal applicants additionally need a SAM.gov UEI and an active Grants.gov account.